HRSA screenshot
Four pharmaceutical manufacturers recently announced 340B refunds or National Drug Code (NDC) changes.

2 Drugmakers to Refund 340B CEs, 2 Others Announce NDC Changes

Two pharmaceutical manufacturers recently informed covered entities that they will receive refunds following 340B ceiling price recalculations, while another two [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
LinkedIn

Site Footer Live